Cancer Genetics Inc. Daily Stock Analysis

Daily Stock Analysis, CGIX, Cancer Genetics Inc, priceseries

Cancer Genetics Inc. Daily Stock Analysis
Stock Information
Open
4.65
Close
4.81
High
5.12
Low
4.61
Previous Close
4.64
Daily Price Gain
0.17
YTD High
697.50
YTD High Date
Sep 30, 2013
YTD Low
1.92
YTD Low Date
Mar 19, 2020
YTD Price Change
-332.69
YTD Gain
-98.57%
52 Week High
7.48
52 Week High Date
Mar 22, 2021
52 Week Low
4.30
52 Week Low Date
Mar 30, 2021
52 Week Price Change
-0.62
52 Week Gain
-11.42%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 16. 2017
75.00
Apr 4. 2017
113.43
13 Trading Days
51.24%
Link
LONG
Apr 19. 2017
109.50
May 3. 2017
124.17
10 Trading Days
13.40%
Link
LONG
Oct 27. 2017
82.50
Nov 8. 2017
90.24
8 Trading Days
9.38%
Link
LONG
Sep 12. 2018
30.00
Sep 26. 2018
34.21
10 Trading Days
14.03%
Link
LONG
Dec 13. 2018
10.95
Dec 17. 2018
13.57
2 Trading Days
23.92%
Link
LONG
Apr 5. 2019
7.81
Apr 10. 2019
8.23
3 Trading Days
5.36%
Link
LONG
Apr 30. 2019
7.78
May 1. 2019
8.31
1 Trading Days
6.88%
Link
LONG
Oct 4. 2019
3.39
Oct 14. 2019
4.00
6 Trading Days
17.99%
Link
LONG
Nov 21. 2019
4.47
Dec 5. 2019
5.92
9 Trading Days
32.50%
Link
LONG
Feb 11. 2020
4.95
Feb 12. 2020
5.32
1 Trading Days
7.47%
Link
LONG
Mar 25. 2020
2.86
Mar 30. 2020
3.03
3 Trading Days
5.94%
Link
LONG
Apr 3. 2020
3.16
Apr 7. 2020
3.39
2 Trading Days
7.28%
Link
LONG
Jun 4. 2020
3.21
Jun 11. 2020
3.41
5 Trading Days
6.15%
Link
LONG
Aug 27. 2020
5.48
Aug 31. 2020
5.82
2 Trading Days
6.20%
Link
LONG
Jan 4. 2021
2.92
Jan 6. 2021
3.11
2 Trading Days
6.51%
Link
LONG
Jan 15. 2021
3.18
Jan 25. 2021
3.85
5 Trading Days
21.07%
Link
LONG
Feb 8. 2021
4.78
Feb 18. 2021
6.11
7 Trading Days
27.82%
Link
Company Information
Stock Symbol
CGIX
Exchange
NasdaqCM
Company URL
http://www.cancergenetics.com
Company Phone
201.528.9200
CEO
Panna L. Sharma
Headquarters
New Jersey
Business Address
201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD, NJ 07070
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001349929
About

Cancer Genetics, Inc. is an early-stage diagnostics company that engages in the development and commercializes proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. Its developments include DNA-FISH Probes, CGH Microarrays and next-generation sequencing treatments. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Description

Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China. Its tests enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor, and inform cancer treatment; and enable biotech and pharmaceutical companies involved in oncology trials to select candidate populations and reduce adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. The company's clinical services provide information on diagnosis, prognosis, and predicting treatment outcomes of cancers to guide patient management. Its biopharma services offer companies with customized solutions for patient stratification and treatment selection through a suite of molecular- and biomarker-based testing services, customized assay development, and trial design consultation. The company's discovery services provide the tools and testing methods for companies and researchers to identify new molecular-based biomarkers for disease. It serves hospitals, cancer centers, clinics, academic institutions, and government-sponsored research institutions, as well as pharmaceutical and biotech companies performing clinical trials. The company collaborates with oncology centers and community-based hospitals to develop its proprietary diagnostic tests. Cancer Genetics, Inc. was founded in 1999 and is based in Rutherford, New Jersey.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading